Heat thErapy And mobiLity in COVID-19 Survivors
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Long COVID
In brief
Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".
Key facts
- Study ID
- NCT06928116
- Run by
- University of Nebraska
- People needed
- 99
- Starts
- 2025-01-16
- Expected to finish
- 2029-08-01
- Last updated by the study team
- 2026-07-17
Who can join
Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Between the ages of 50 and 90 years
- Free from orthopedic limitations that would prohibit performing leg exercise
- BMI < 40 kg/m2 and weigh < 400lbs
- Previously contracted Covid-19 and have persistent symptoms such as a fatigue or decline in physical function, for at least 2 months following SARS-CoV-2 infection
You may not qualify if…
- Unable to give written informed consent
- Women who are pregnant, breastfeeding, or likely to become pregnant within the next 6 months
- Women who are taking hormone therapy
- Claustrophobia
- Orthopedic limitations that would prohibit them from walking
- Currently enrolled in an exercise-based or respiratory muscle rehabilitation program.
Where it is running
- University of Nebraska Omaha — Omaha, Nebraska, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.